The US FDA has granted approval for the first oral pill designed to treat high cholesterol, offering an alternative to traditional injectable medications.
This medical development aims to simplify treatment regimens for patients managing cholesterol levels, marking a shift in standard cardiovascular care protocols.
The approval follows extensive clinical evaluation of the drug's efficacy and safety profile, providing a new therapeutic option for long-term cholesterol management.